MOUNTAIN VIEW, Calif., Oct. 23, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that the Omnicell VBM 200F Multimed Automation has strong commercial momentum and customer adoption globally including in the U.S., U.K, Germany, and China.
The Omnicell VBM 200F has been adopted into a variety of pharmacy settings serving different patient communities, including chain and independent closed-door pharmacies, retail pharmacies, and specialty pharmacies. It is the only small footprint automated pharmacy solution that efficiently and accurately fills and checks SureMed® by Omnicell® Multimed Blister Cards.
"BJRx has always been committed to patient safety and improved heath, and investing in the VBM 200F advanced automation supports this mission. We are pleased to be able to offer both our retail patients and nursing facility customers these blister cards that are proven to help simplify the process of taking medications and following physician's prescribed regimens," said Jeannie Duckworth, Regional Long-Term Care Sales Director of BJRx, a pharmacy chain in San Joaquin Valley, Calif. "We know that when patients take their medications correctly, they are able to live healthier lives, and this also helps to reduce emergency room and non-scheduled physician visits."
SureMed blister cards help improve patient adherence by sorting multiple types of medications by both day of the week and time of day in an easy-to-understand format, helping patients remain adherent to their prescribed medication regimens. Automating the filling and checking of SureMed cards with the Omnicell VBM 200F allows pharmacies to have an even greater impact on healthcare in their communities.
"Adding this automated solution was an obvious move for our facility as we looked to provide for more patients in our community and partner with other types of care providers," said Stephen MacNeill, RPh, Winchester Pharmacy Owner and President in Winchester, Mass. "As a retail pharmacy, our customers rely on us to provide an easy-to-use product that ensures their loved ones' safety when managing medications at home. The VBM 200F allows us to easily provide this invaluable service in a timely, cost-effective manner that doesn't place additional strain on my pharmacy team."
A Seattle-based pharmacy serving long-term care patients is also benefiting from the Omnicell VBM 200F. "We pride ourselves on offering a high quality, flexible adherence solution that enhances patient safety and peace of mind for our independent patients who reside in long-term care facilities," said Stephen Boulanger RPH, President of Mercury Pharmacy Services, Inc. in Seattle, Wash. "The VBM technology is paramount in our ability to scale our business to meet the growing demands of our assisted-living and independent-living customers."
"We are incredibly pleased with the level of global enthusiasm the VBM 200F has received," said Troy Hilsenroth, vice president and general manager, Medication Adherence Division at Omnicell. "This solution helps elevate pharmacies looking to provide exceptional services to their customers, and we find its reception promising as we continue to innovate for the future."
The Omnicell VBM 200F pharmacy automation solution is an integral part of the Omnicell Platform and Medication Adherence ecosystem driving and enabling automation, efficiency, safety and adherence in retail and specialty pharmacies.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
For more information about Omnicell, Inc. please visit www.omnicell.com.
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
View original content with multimedia:http://www.prnewswire.com/news-releases/omnicells-vbm-200f-pharmacy-automation-has-global-customer-adoption-success-in-a-variety-of-pharmacy-settings-300541032.html
SOURCE Omnicell, Inc.